I won't be responding to Insulas post, not because I dont believe in being disrespectful as he has been, but because I dont actually think he understood my jestful post to Lockitt, as I dont understand his retort and so will just leave it at that.
Lockitt made a comment that is essentially fact that, if a bio company's trials fail, then the SP will fail too, to which my reply, of telling him jokingly that saying this re PER is blasphemy, is because I will not hear of anyone saying PER trials will be anything but successful ...
so for Insula to reply with his response which I assume means my post was putting PER down when it clearly was doing the exact opposite is something I dont understand.
Insula has also inferred that I have spent more time on the ** platform where I am some sort of elected member and come back to HC to post negative posts ,when, in fact, my post today was positive, and I have not been on the ** platform or HC for some time further to my own health issues and more recently my wife ...
Last year Dec I predicted that in the absence of news on a partnership we would see the SP remain sub 10c until the end of this year when any successful trial results result in a rerating .
So far this seems to be working for me and I have used Lockitts posts on gaps to time purchases for myself and my boys to try and maximise the relatively small holdings we do now have to maximise the ROI I have no doubt we will experience when those trial results come in as successful so that I can shout an extra round of fries at the Maccas celebration
dave
PER Price at posting:
8.3¢ Sentiment: Buy Disclosure: Held
